LTR Pharma (ASX:LTP) Dividends per Share: A$0.00 (TTM As of Dec. 2025)


ASX:LTP LTR Pharma Ltd ASX:LTP
15 GF Score
Price A$0.58
View Full Analysis

What is LTR Pharma Dividends per Share?

LTR Pharma ASX:LTP +6.48% 15 Dividends per Share is A$0.00 as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 15/100.

LTR Pharma's dividends per share for the six months ended in Dec. 2025 was A$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00. Its Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00. As of today, LTR Pharma's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

LTR Pharma  (ASX:LTP) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

LTR Pharma's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0/ -0.032
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Dividends per Share Related Terms

LTR Pharma Dividends per Share Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Dividends per Share Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Dividends per Share
0.00 0.00 0.00 0.00 0.00

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividends per Share Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

ASX:LTP vs VRTX, REGN, ALNY: Dividends per Share Comparison

For the Biotechnology subindustry, LTR Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LTR Pharma Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where LTR Pharma's Dividend Yield % falls into.


ASX:LTP
15GF Score
LTR Pharma Ltd ASX:LTP
Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of A$0.00 mean?
LTR Pharma (ASX:LTP) has a Dividends per Share of A$0.00 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on LTR Pharma and its competitors.
Is LTR Pharma's Dividends per Share too high?
LTR Pharma's current Dividends per Share is A$0.00. Overall, LTR Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Dividends per Share compare to VRTX and REGN?
LTR Pharma's Dividends per Share of A$0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Biotechnology company?
A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on LTR Pharma and its competitors. LTR Pharma's current Dividends per Share is A$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Dividends per Share of A$0.00. The current Dividends per Share is A$0.00. LTR Pharma's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Dividends per Share is A$0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
15GF Score

Get the complete analysis for ASX:LTP

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.58
Price